Agenda

All Times are Eastern Time Zone

Friday, October 21, 2022
Advances in Drug Therapy12:45 PM - 2:00 PM
Update on Encalaret treatment for ADH1 and other forms of Hypopara2:10 PM - 3:20 PM
Clinical Development 1013:30 PM - 4:05 PM
Update AZP-3601 Treatment for Hypopara4:15 PM - 5:30 PM
Rare X what it means for a Hypopara Patient5:40 PM - 6:45 PM
Saturday, October 22, 2022
Link open-Q&A open to collect questions10:15 AM - 10:30 AM
Fractures and Cataracts10:30 AM - 11:45 AM
Patient Reported Outcomes in Hypoparathyroidism: Measuring the Humanistic Burden12:00 PM - 1:15 PM
Break1:15 PM - 1:30 PM
Conventional Treatment of Hypoparathyroidism1:30 PM - 2:30 PM
Living with Hypopara with and without PTH replacement. Case presentations 2:45 PM - 4:00 PM
HPA update4:15 PM - 4:45 PM
Advocacy: More than letters and Capital Hill4:45 PM - 5:15 PM
Sunday, October 23, 2022
Link open-Q&A open to collect questions10:15 AM - 10:30 AM
Long term effects of hypoPARA10:30 AM - 11:45 AM
Clinical Development Program Calcilytix12:00 PM - 1:15 PM
Closing-Carrying on as a patient with Hypopara1:15 PM - 1:30 PM